Abstract
Thrombotic microangiopathy (TMA) causes defects in capillary endothelium which can lead to renal allograft damage. TMA may occur as recurrent or de novo in renal transplant recipients. This is relatively rare, yet, can have significant impact on graft survival. Genetic abnormalities associated with post transplant thrombotic microangiopathy are yet to be fully elucidated.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
